Link Pharma Chem Limited (BOM:524748)
27.00
-1.00 (-3.57%)
At close: Jun 1, 2026
Link Pharma Chem Revenue
In the fiscal year ending March 31, 2026, Link Pharma Chem had annual revenue of 276.35M INR with 8.66% growth. Link Pharma Chem had revenue of 65.89M in the quarter ending March 31, 2026, with 2.21% growth.
Revenue
276.35M
Revenue Growth
+8.66%
P/S Ratio
0.43
Revenue / Employee
3.33M
Employees
83
Market Cap
119.90M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 276.35M | 22.02M | 8.66% |
| Mar 31, 2025 | 254.33M | -44.64M | -14.93% |
| Mar 31, 2024 | 298.98M | -88.60M | -22.86% |
| Mar 31, 2023 | 387.58M | -148.03M | -27.64% |
| Mar 31, 2022 | 535.61M | 187.48M | 53.85% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Supha Pharmachem | 5.27B |
| Smruthi Organics | 1.02B |
| Resonance Specialties | 918.89M |
| Tyche Industries | 505.54M |
| Vasundhara Rasayans | 386.27M |
| Crestchem | 266.14M |
| Krebs Biochemicals & Industries | 237.32M |
| Ishita Drugs and Industries | 161.68M |